Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 139 citing Edelman: Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchocon.... (0.09 sec) 

Leukotrienes


M Peters-Golden, WR Henderson Jr - The New England journal of medicine, 2007 - nejm.highwire.org
Leukotrienes ("leuko," from white blood cells; and "trienes," three conjugated
double bonds) comprise a family of products of the 5-lipoxygenase pathway of
arachidonic acid metabolism. The cysteinyl leukotrienes C 4 , D 4 , and E 4 ...
Cited by 99 - Related articles - BL Direct - All 5 versions

Evaluation of Salmeterol or Montelukast as Second-Line Therapy for Asthma Not Controlled …

- chestpubs.org
AM Wilson, OJ Dempsey, EJ Sims, BJ … - Chest, 2001 - chestjournal.chestpubs.org
Wilson, Andrew M.; Dempsey, Owen J.; Sims, Erika J.; Lipworth, Brian J.
Cited by 84 - Related articles - BL Direct - All 6 versions

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma

- bmj.com [PDF] 
MJ Vaquerizo, P Casan, J Castillo, M Perpina, … - British Medical Journal, 2003 - thorax.bmj.com
A correction has been published for this article. The contents of the ...
Effect of montelukast added to inhaled budesonide on ... MJ Vaquerizo, P Casan,
J Castillo, M Perpiña, J Sanchis, V Sobradillo, A Valencia, H Verea, JL ...
Cited by 75 - Related articles - BL Direct - All 8 versions

Effect of long-acting b2 agonists on exacerbation rates of asthma in children


H Bisgaard - Pediatric pulmonology, 2003 - interscience.wiley.com
The purpose of this analysis was to examine the effect of long-acting 2
-adrenoceptor agonists (LABAs) on the asthma exacerbation rate in pediatric
patients. Randomized controlled trials (RCT) that included the use of LABAs ...
Cited by 73 - Related articles - BL Direct - All 5 versions

A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and …


AM Wilson, OJ Dempsey, EJ Sims, BJ … - Clinical & Experimental Allergy, 2001 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 66 - Related articles - BL Direct - All 4 versions

Pharmacology of airway inflammation in asthma and COPD


G Caramori, I Adcock - Pulmonary pharmacology & therapeutics, 2003 - Elsevier
The current asthma therapies are not cures and symptoms return soon after
treatment is stopped even after long term treatment. Although inhaled
glucocorticoids are highly effective in controlling airway inflammation in ...
Cited by 55 - Related articles - All 6 versions

Past, present and future—β2-adrenoceptor agonists in asthma management


MR Sears, J Lötvall - Respiratory medicine, 2005 - Elsevier
The β-adrenoceptor agonists (β-agonists) have been used to relieve
bronchoconstriction for at least 5000 years. β-agonists are based on adrenaline
and early forms, such as isoprenaline, lacked bronchial selectivity and had ...
Cited by 52 - Related articles - All 9 versions

Is there a problem with inhaled long-acting β-adrenergic agonists?


HS Nelson - The Journal of Allergy and Clinical Immunology, 2006 - Elsevier
Short-acting β 2 -agonists are effective in relieving acute symptoms of asthma
and in the short-term prevention of symptoms from stimuli, such as exercise.
They are ineffective when used on a regular schedule to improve asthma ...
Cited by 53 - Related articles - All 54 versions

The role of leukotrienes in asthma


SE Wenzel - Prostaglandins, Leukotrienes & Essential Fatty Acids, 2003 - Elsevier
Leukotrienes (LT), both the cysteinyl LTs, LTC 4 , LTD 4 and LTE 4 , as well as
LTB 4 have been implicated in the clinical course, physiologic changes, and
pathogenesis of asthma. The cysteinyl LTs are potent bronchoconstrictors, ...
Cited by 49 - Related articles - All 10 versions

Montelukast: a review of its therapeutic potential in persistent asthma


B Jarvis, A Markham - Drugs, 2000 - ingentaconnect.com
Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . 892 1. Therapy for Persistent Asthma . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 896 1.1 The ...
Cited by 45 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google